Advertisement

Topics

ALK readies Odactra launch after Merck exit

06:29 EDT 22 Aug 2017 | BioPharmaDive

The Danish drugmaker is ready to launch its house dust mite treatment after its big pharma partner pulled out of the collaboration in 2016.

Original Article: ALK readies Odactra launch after Merck exit

NEXT ARTICLE

More From BioPortfolio on "ALK readies Odactra launch after Merck exit"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...